These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antenatal screening in Oxford for fetal neural tube defects. Wald NJ; Cuckle HS; Boreham J; Brett R; Stirrat GM; Bennett MJ; Turnbull AC; Solymar M; Jones N; Bobrow M; Evans CJ Br J Obstet Gynaecol; 1979 Feb; 86(2):91-100. PubMed ID: 85462 [TBL] [Abstract][Full Text] [Related]
5. Early pregnancy screening for neural tube defects in Israel. Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475 [TBL] [Abstract][Full Text] [Related]
6. Maternal serum alpha-fetoprotein screening for the detection of neural tube defects. Crandall BF; Robertson RD; Lebherz TB; King W; Schroth PC West J Med; 1983 Apr; 138(4):524-30. PubMed ID: 6191442 [TBL] [Abstract][Full Text] [Related]
7. Maternal serum alpha-fetoprotein screening in a provincial Health District. Woolfson J; Holt EM; Whyman AE; Mabbs DV Br J Obstet Gynaecol; 1979 Feb; 86(2):87-90. PubMed ID: 85461 [TBL] [Abstract][Full Text] [Related]
8. Cost-justification analysis of prenatal maternal serum alpha-feto protein screening. Taplin SH; Thompson RS; Conrad DA Med Care; 1988 Dec; 26(12):1185-202. PubMed ID: 2462141 [TBL] [Abstract][Full Text] [Related]
9. Is maternal alpha-fetoprotein screening still of value in a low-risk area for neural tube defects? Hooker JG; Lucas M; Richards BA; Shirley IM; Thompson BD; Ward RH Prenat Diagn; 1984; 4(1):29-33. PubMed ID: 6203108 [TBL] [Abstract][Full Text] [Related]
10. Impact of maternal serum alpha-fetoprotein screening on antenatal diagnosis. Brock DJ Br Med J (Clin Res Ed); 1982 Jul; 285(6338):365-7. PubMed ID: 6178461 [TBL] [Abstract][Full Text] [Related]
11. Screening for fetal malformations using ultrasound and measurements of alpha-fetoprotein in maternal serum. Persson PH; Kullander S; Gennser G; Grennert L; Laurell CB Br Med J (Clin Res Ed); 1983 Mar; 286(6367):747-9. PubMed ID: 6186332 [TBL] [Abstract][Full Text] [Related]
12. Prenatal screening for fetal aneuploidy in singleton pregnancies. Chitayat D; Langlois S; Douglas Wilson R; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752 [TBL] [Abstract][Full Text] [Related]
13. Parent preferences and prenatal testing for neural tube defects. Ennever FK; Lave LB Epidemiology; 1995 Jan; 6(1):8-16. PubMed ID: 7534119 [TBL] [Abstract][Full Text] [Related]
14. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome. Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657 [TBL] [Abstract][Full Text] [Related]
15. When does mass screening for open neural tube defects in low-risk pregnancies result in cost savings? Tosi LL; Detsky AS; Roye DP; Morden ML CMAJ; 1987 Feb; 136(3):255-65. PubMed ID: 2433011 [TBL] [Abstract][Full Text] [Related]
19. Maternal serum alpha-fetoprotein monitoring. Council on Scientific affairs. JAMA; 1982 Mar; 247(10):1478-81. PubMed ID: 6173496 [TBL] [Abstract][Full Text] [Related]
20. Prenatal diagnosis policy without routine amniocentesis in pregnancies with a positive family history for neural tube defects. Papp Z; Tóth Z; Török O; Szabó M Am J Med Genet; 1987 Jan; 26(1):103-10. PubMed ID: 2433941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]